Dihydrate of iron (ii) hydroascorbate riboflavinate for improving growth and development of chickens

FIELD: agriculture.

SUBSTANCE: invention relates to a novel compound - dihydrate of iron (II) hydroascorbate riboflavinate

(II) Fe(C6H7O6)(C17H19O6N4)2H2O which is used as an additive.

EFFECT: improved development and growth of chickens.

1 cl, 1 ex, 1 tbl

 

The invention relates to new chemical compounds used to improve the growth and development of chickens.

This compound can be applied in poultry, in particular, as feeding a growing chickens.

In the practice of feeding birds use various additives to improve its growth and development. Of particular importance among these compounds are vitamins, particularly Riboflavin and ascorbic acid.

It is known that Riboflavin (vitamin b2included redox enzymes, which affect the metabolism of proteins, fats, nucleic acids and some vitamins - Pantothenic, folic and orotovoy acids, choline and pyrodoxine, it also provides the normal function of sexual glands and the nervous system [1].

Vitamin C participates in redox processes, in the transformations of nucleic acids in the synthesis of steroid hormones in the adrenal cortex, in education reference proteins (collagen) and proteins of the connective tissue, promotes the formation and accumulation of glycogen in the liver, stimulates the secretion of gastric glands, activates a number of enzymes that affect the metabolism of sulfur [2, 3].

Also known additives for poultry, representing complex compounds of iron and copper with Riboflavin and alpha-amino acids [4] and gamma-aminobutyric acid [5]. For example, note the imposition of the most effective of these compounds of iron complex with Riboflavin and gamma-aminobutyric acid in the feeding of young birds allows you to increase the gain in live weight of chickens by 11.6%.

Has not previously been described compound of iron with ascorbic acid and Riboflavin, suitable as additives in the diet when feeding birds.

The invention is directed to the synthesis of compounds of the dihydrate of hydrobromination iron (II)to extend the range of dietary supplements designed to improve the development and growth of chickens.

The invention is a dihydrate hydrobromination - laminat iron (II), has the following formula: Fe(C6H7O6)(C17H19O6N4)·2H2O and is intended to improve the growth and development of chickens.

Named the invention dehydrate hydrobromination iron (II) was prepared as follows.

0.5 liter of 0.2 n sodium hydroxide solution is dissolved 18,81 g Riboflavin and 8,80 g of ascorbic acid. In the resulting solution contribute to 13.9 g semimodule of ferrous sulfate (FeSO4·7H2O) and the formed slurry is maintained at a temperature of 70-80°C under mechanical stirring for 5-6 hours before moving yellow suspension in light brown. The finished product is filtered, washed with water until a negative reaction to sulfate ions and dried in a drying Cabinet at a temperature of 100-110°C.

The compound is obtained as an amorphous light brown powder, in which the course is 89%.

Connection odourless, non-hygroscopic, stable during storage, solubility 0,362 g in 100 g of water, little soluble in ethanol and insoluble in organic solvents (benzene, chloroform, and others). In neutral and slightly alkaline aqueous solution of the compound barely breaks down into simple components.

When analyzing the connection is found, wt.%: Fe - 8,66, 43,12, N - Br4.61, 34,96, N - 8,65, C17H19O6N4- 58,52,6H7About6- 27,09, N2On - 5,73.

Calculated, wt.%: Fe - 8,72 - 42,99, N - 4,67, 34,89, N - 8,72, C17H19O6N4- 58,41,6H7About6- 27,25, N2On - 5,62.

The calculated molar mass of compound 642, temperature dehydration 135°C. at 220°C, the compound decomposes without melting.

The IR spectrum of Riboflavin are intense bands with frequencies 1740 and 1648 cm-1characteristic frequencies of its carbonyl group νSt(C(4)=O) and νas(C(4)=O), and the absorption band of medium intensity νas(N(5)O-n) frequency 3214 cm-1. In the IR spectrum of compound has no absorption bands with frequencies 3214, 1740 and 1648 cm-1that proves coordinatie Riboflavin with iron ions(P) in deprotonated enol form, with the formation of chelate cycle due to the heteroatom of nitrogen (N(5)and neighboring enol ( (4)) oxygen atom. In the spectrum of Riboflavin also has absorption lines related to the condensed cycles (ν(C=C)=1620, ν(C=N)=1580, ν(Carene.-N=1247, σ(=C-H)arene=882 cm-1), which are observed with a small offset in the IR spectrum of compound (1605, 1578, 1255 and 873 cm-1respectively.

The IR spectrum of ascorbic acid have absorption bands related to the stretching vibrations of C=O groups ((νco=1730), deformation vibrations of the Oh-group at C(2)-atom (δ(he)=1320 cm-1and when With(3)-atom ascorbic acid (δ(he)=1220 cm-1). In the IR spectrum of compound strip deformation vibrations of the Oh-group at C(2)-atom shift in the high frequency region (1330 cm-1), which indicates the coordination of the oxygen atom of this group with a metal ion, and there is no band, related to the deformation vibrations of the Oh-group at C(3)-atom ascorbic acid (δ(he)=1220 cm-1), due to the ionization of this group and formation of Fe-O.

The individuality of the obtained compounds was confirmed by TLC with chromatographytandem in the system ISO-butyl alcohol - formic acid - water (5:1:1). Compound forms on the chromatogram individual spot, the value of Rf=0,15 which differs from RfRiboflavin, ascorbic acid and the compounds with iron (II), with Rfin the interval 0,22-0,57.

The data of chemical analysis, IR spectroscopy and TLC allow to ascribe to the compound of the following structural formula:

Action dihydrate of hydrobromination iron(II) was studied in chickens pullets of laying hens of the cross "Hisexs brown" at the age of 30 days within 1 month on four groups of chickens 100 animals each, formed on the principle of analogues (table).

Table
GroupCf. live weight at the beginning, gThe average live weight at the end, gThe average increase in live weight, gThe average increase in live weight, %
Experienced 1319692373109,1
Experienced 2314705391114,3
Experienced 3316702386of 112.8
Control317659342100

The first group was the control, i.e. as a feed received only the basic diet In the diet of the second, third and fourth groups instead Riboflavin, part of the feed, respectively, were injected additive complex compounds at the rate of 5, 10 and 15 mg per 1 kg of feed. The safety population in the control and experimental groups during the test was 100%.

Adding complex compounds of iron, Riboflavin and ascorbic acid in the basic diet instead of Riboflavin has a positive effect on the growth and development of Chicks and leads to an increase in their body weight 9.1-14.3 per cent compared with a control group that did not receive this connection.

Thus, studies have shown that a new connection dehydrate hydrobromination iron (II) is an effective additive that increases the gain of chickens to 14.3%, while the complex compound of iron, Riboflavin and gamma-aminobutyric acid increases the gain in live weight of chickens only 11.6%.

Sources of information

1. Jortner B.S., Cherry J. Peripheral neuropathy of dietary riboflavin defi ciency in chickens //Journal of neuropathology and Experimental neurology - 1987. - V.46. - N 5. - P.544-555.

2. Davis, M., Austin, J., Patridge D. The Vitamin Is. Chemistry and biochemistry. - M.: Mir, 1999. - 176 S.

3. Brake J. Pardue, S.L. Role of ascorbic acid in poultry nutrition // Proc. of 10th Europ. Poultry conf. - Ierusalem, 1998. - P.63-67.

4. Hooks Century, Kryvtsov Century Gamma-aminobutyric acid in the diet of Chicks /Poultry. - 1990. No. 2. - P.21-22.

5. Friedman AT New biologically active compounds and prospects for their use, " Izv. An Kirg. SSR, Chemical engineering science. - 1988. No. 4. - P.21-27.

6. Kebets A.P., Kebets NM Trihydrate gamma aminoethylethanolamine iron (II)intended for the improvement and growth of Chicks. Patent for invention No. 2246848 EN, IPC7AC 1/00, 1/16. Publ. 27.02.2005. Bull. No. 6.

Dehydrate hydrobromination iron (II) formula Fe(C6H7O6)(C17H19O6N4)2H2O designed to improve growth and development of Chicks.



 

Same patents:

FIELD: chemistry.

SUBSTANCE: invention relates to 1-alkenylimidazole derivatives of general formula 1 , where R is vinyl, allenyl or isopropenyl, R1 is hydrogen or methyl, E is Zn (II) or Fe(III), An is chlorine or acetate, n equals 1, 2 or 4, except compounds where R is vinyl, R1 is hydrogen, E is Zn(II), An is chlorine or acetate and n equals 2.

EFFECT: compounds have antihypoxic properties for different types of hypoxia.

5 ex, 8 tbl

FIELD: process engineering.

SUBSTANCE: invention relates to complete methane oxidation catalysts and can be used in industries using diesel fuel. Invention covers complete methane oxidation catalysts based on strontium hexaferrites of the following composition: SrMnxFe12-xO19, where x=0, 1, 2, 6. Proposed method comprises settling catalyst components with the help of NH4HCO3 solution at constant pH equal to (7.1 to 8.0) and temperature not lower than 70°C with subsequent stages of filtration, rinsing, drying and roasting. Proposed method comprises also the stage of heat treatment at 800° to 1000° C and is realised in the presence of above described catalysts.

EFFECT: high degree of methane conversion at relatively low temperatures.

6 cl, 2 tbl, 14 ex

FIELD: chemistry.

SUBSTANCE: invention relates to a polyolefin synthesis method and more specifically to a polyethylene synthesis method. Polyethylene is a copolymer of ethylene with 1-alkenes. The invention also relates to polyethylene synthesis catalyst systems. The catalyst system is a mixture of metallocenes: hafnocene and an iron-based complex, an activating compound and a support. The invention also relates to films made from polyethylene and packets made from the said films.

EFFECT: disclosed catalyst system enables production of polyethylene with given molecular weight distribution in a single reactor.

16 cl, 3 tbl, 3 ex

FIELD: chemistry.

SUBSTANCE: invention relates to a method of producing iron (II) oxalate by directly reacting metal with acid in the presence of atmospheric oxygen and a liquid phase while stirring. The process is carried out in a bead mill. The liquid phase solvent used is water with mass ratio of the liquid phase to glass beads equal to 1:1, content of oxalic acid in the initial load is between 0.5 and 2.0 mol/kg, and content of stimulating sodium chloride additive is between 0.02 and 0.10 mol/kg. Crushed grey cast iron which is stirred by a blade mixer is taken in amount of 30% of the mass of the rest of the load. The process is started and carried out at temperature in the interval from (50±2) to (93±2)°C while bubbling air under conditions for stabilising temperature using a heated liquid bath and controlling using a sample taking method and determination of content of iron (II) and (III) salts in the samples, and residual quantity of acid up to virtually complete conversion of the latter into salt. After that air bubbling, external heat supply for stabilising temperature and stirring are stopped. The suspension of the reaction mixture is separated from the glass beads and particles of unreacted metal alloy and filtered. The filtration residue is washed with distilled water and taken for further purification through recrystallisation, while the filtrate and the washing water are returned to the load for the repeated process. Iron (II) oxalate, which is separated from the reaction mixture by traditional filtering, is virtually the only product of conversion.

EFFECT: liquid phase used together with the sodium chloride additive can be repeatedly returned to the process.

10 ex, 1 tbl

FIELD: chemistry.

SUBSTANCE: iron (II) fumarate can be used in different fields of chemical practice, in analytical control and in scientific research, through direct reaction of iron with fumaric acid in the presence of a catalyst, where the catalyst used is molecular iodine in amount of 0.025 to 0.1 mol/kg of the initial load, iron is taken in large excess in form of shells on the entire height of the reactor, false bottom and blade mixer, as well as in form of crushed cast iron and(or) reduced iron powder, the liquid phase solvent used is butylacetate, in which iodine and fumaric acid are at least partially dissolved, where fumaric acid is taken in amount of 0.8 to 1.2 mol/kg of the initial load, loading is done in the sequence: glass beads, liquid phase solvent, fumaric acid, iodine, and then crushed cast iron and(or) reduced iron powder; the process is started at room temperature and is carried out in a vertical type bead mill with ratio of mass of beads to mass of crushed cast iron and(or) reduced iron powder equal to 4:1, at temperature ranging from 18 to 45°C while bubbling air with flow rate of 0.95 l/min-kg of the liquid phase and using forced cooling and controlling using a sampling method until complete exhaustion of the loaded acid for formation of salt, after which stirring and cooling are stopped, the reaction mixture is separated from glass beads and unreacted crushed cast iron and(or) reduced iron powder and filtered, the residue is washed with butylacetate and taken for recrystallisation, and the filtrate and washing butylacetate are returned to the repeated process. Amount of acid used in extracting the product (without loss during purification) ranges from 89 to 96.5%, which depends on conditions for carrying out the process.

EFFECT: improved method of producing said product.

8 ex

FIELD: chemistry.

SUBSTANCE: invention refers to coordination chemistry: specifically, to improved method of producing heterometal neodymium (III) and iron (III) malate of formula 1 to be used for synthesis of mixed oxides of perovskite composition. . Method is enabled by electrolysis of concentrated aqueous solution of neodymium (III) nitrate and malic acid in ratio 1:3 with pyridine or lithium perchlorate with anode added, pressed from recovered iron, and inert cathode from graphite with using pulse current of variable porosity. Thereafter the solution is evaporated with precipitation then washed with ethanol and dried.

EFFECT: method is cost-effective, controlled and productive.

3 cl, 3 tbl, 1 dwg

FIELD: chemistry.

SUBSTANCE: as catalyst substituted iron phthalocyanines of general formula ,

where R=[CH2N+(CH3)2CH2CH2OH]Cl-, L=(CH3)2NCH2CH2OH (I);

R=[CH2N+(CH3)2CH2CH2N(CH3)2]Cl-, L=(CH3)2NCH2CH2N(CH3)2 (III);

are used. Oxychlorination is carried out with mixture of H2O2 and HCl in water-alcohol medium in presence of suggested catalyst.

EFFECT: simplification of technology of obtaining chlor-derivatives of aromatic hydrocarbons with good yield and quality of product.

2 cl, 19 ex

FIELD: chemistry.

SUBSTANCE: invention concerns improved method of obtaining mevalonic acid derivatives of the general formula I or its pharmaceutically acceptable salt with base, or lactone, where -CH2-CH2- or -CH=CH-, R is heterocyclical residual of interaction of compound of the general formula IIa , where R1, R2, R3, R4 meanings are described in the invention, with compound of the general formula IIb: R-CH(=O) where R is cyclical residual. Obtained compound is recovered in the presence of recovery agent, preferably a compound of the formula IId , where M is Ru, Rh, Ir, Fe, Co, Ni, L1 - H, L2 - aryl, R5 is aliphatic residual, R8 and R9 are C6H5 or form cyclohexane ring or cyclohexane or cyclopentane ring combined with C atom, to which they are bound, with a number of further stages.

EFFECT: high product output.

4 cl, 1 ex

FIELD: salts of iron and organic acid producing processes, namely production of salt of iron (III) and acetic acid.

SUBSTANCE: method is realized by relation of metallic iron with acetic acid at presence of oxidizing agent; using molecular iodine, iron oxides such as Fe2O3, Fe3O4 and oxygen of air as oxidizing agent for converting impurity of iron (II) acetate to basic iron (III) acetate. Process is performed in beads mill at temperature 80°Cand at mass relation of liquid charge and glass beads 1 : 1. Iron is used in the form of shell abutted to lateral surface of reactor housing. Initial molar relation of iron oxide and iodine is 10 : 1. Molar relation of acetic acid, its anhydride and iron oxide is in range 100 : (2 - 5.99) : (2 - 2.5). In time moment of practically complete consumption of iron oxide, solid phase of reaction mixture is taken off by filtering. Simultaneously consumed reagents are replenished and filtrate is returned to reactor for repeating process. Number of processes to be repeated is no more than 5. At second stage residues of iron (II) salt are after-oxidized to basic iron (III) acetate due to drying up taken off solid phase of product in filter by means of blowing air at environmental temperature. Preferably, hematite, γ-oxide or minimum is used as Fe2 O 3 and magnetite and Fe3O4 x 4H2Ois used asFe3 O4.

EFFECT: simplified process, usage of available reagents.

3 cl, 9 notes, 2 tbl

FIELD: coordination compound chemistry.

SUBSTANCE: invention relates to technology of complexes of iron with salicylic acid suitable for use in a variety of technical areas and in medicine. Title complex is obtained via interaction of metal with acid using air oxygen as oxidant. Salicylic acid is used in butyl acetate or n-butyl alcohol solution with dissolved molecular iodine or potassium iodide. Iron is provided in the form of steel or cast iron shell, shaft, and blade of mechanical mixer as well as, agitated by the mixer, reduced iron powder fractions, broken cast iron or broken steel cuttings, cast iron or steel filings. Process is carried out at stirring with high-speed mechanical stirrer and air bubbling allowing self-heating of reaction mixture to 70-80°C until 1.72-1.85 mole/kg iron compounds is accumulated in reaction mixture in the form of suspension, whereupon mixing is stopped. Suspension is freed of unreacted fine iron and/or alloy(s) thereof and subjected to hot filtration, Filtrate is warmed to eliminate precipitated solid phase and then slowly cooled to ambient temperature. Precipitated solid phase is filtered off, dried, and recrystallized, while filtrate is recycled.

EFFECT: improved technology required only accessible starting materials and increased yield of desired product.

2 cl, 4 ex

FIELD: organic chemistry, biochemistry, biology.

SUBSTANCE: invention relates to a pharmaceutical composition eliciting the inhibitory effect on activity of serine protease (caspase-3) in the form of tablet, capsule or injections placed into acceptable package, to a method for its preparing and a method for treatment of diseases associated with enhanced activation of apoptosis. The composition comprises compound 2,3-dihydro-1H-benzo[g]pteridine-4-one of the general formula (1) (1)

or its salt with pharmacologically acceptable acid as an active component taken in pharmaceutically effective amount wherein X means oxygen (O) or sulfur (S) atom; R1 and R2 represent independently of one another hydrogen atom, inert substitute taken among the group including low- or non-reactive and optionally substituted radical, such as (C1-C7)-alkyl, (C2-C7)-alkenyl, (C2-C7)-alkynyl, (C1-C7)-alkoxy-group, (C7-C12)-aralkyl, (C7-C12)-heterocyclylalkyl, (C7-C12)-alkaryl, (C3-C10)-cycloalkyl, (C3-C10)-cycloalkenyl, phenyl, aryl, heterocyclyl; optionally substituted hydroxy-(C1-C5)-alkyl group; R3, R4, R5 and R6 represent independently of one another hydrogen, halogen atom, -CF3, -CN, inert substitute taking among the group including low- or non-reactive and optionally substituted radical, optionally substituted hydroxyl group, optionally substituted hydroxy-(C1-C5)-alkyl group, optionally substituted amino-group, optionally substituted amino-(C1-C7)-alkyl group, optionally substituted carboxy-(C1-C7)-alkyl group, optionally substituted (C1-C6)-alkylcarboxy-(C1-C6)-alkyl group, optionally substituted carbamoyl group, optionally substituted (C1-C6)-alkylcarbamoyl group, optionally substituted sulfamoyl group. Also, invention relates to applying compounds of the formula (1) for preparing pharmaceutical composition and experimental study (in vitro and in vivo) processes associated with apoptosis.

EFFECT: improved preparing method, valuable medicinal and biochemical properties of composition.

7 cl, 1 dwg, 2 tbl, 5 ex

FIELD: agriculture.

SUBSTANCE: invention refers to veterinary. Forage composition contains the following components: riboxinum, calcium glycerophosphate, fructose, methyluracul, vitamin B12, ascorbic acid, citric acid, succinic acid, folic acid, glucose, chitosan, olygofructose and inuline at ratio 30/70, sources of protein, fats and poly- non-saturated fat acids at specified ratio of components. As components retarding lipogenesis in liver forage also contains: phospholipids - lecithin, L-carnitine, and β-carotene. As protein sources forage also contains soya bean flour, soya bean ground oil cake, and rape-cake. Also as sources of fats and poly-non-saturated fatty acids forage contains fish oil and linseed oil.

EFFECT: forage provides fortification of immunity and can be used for accelerated growth and for retarding development of liver hepatosis of agricultural and domestic animals and birds and fish.

4 tbl, 3 ex

FIELD: food industry.

SUBSTANCE: invention concerns feeding of pets. Fluid composition is proposed for oral consumption for assistance of increased water consumption containing fermentatively processed liver in quantity from 1 to 20 % wt mixed with water. Method of pet feeding with mentioned composition.

EFFECT: invention allows to increase speed of urine production as preventive measure of disorder of urinary tract lower department.

12 cl, 5 tbl, 5 ex

New application // 2353362

FIELD: medicine.

SUBSTANCE: invention refers to medicine and veterinary science and concerns applications of 4-trifluoromethylbenzyl ester (S)-3-[3-(1-carboxy-1-methylethoxy)phenyl]piperidine -1-carboxylic acid in preparation of a medical product for palliative, preventive or medicinal therapy of negative energy balance in ruminants, where said disease is chosen from fatty liver syndrome, allotopia, dysimmunity, immunosuppression, toxification, primary and secondary ketosis, cow mortality syndrome, digestive disorder, appetite loss, retained placenta, slipped abomasum, mastitis, (endo-)-metritis, barrenesses, low fertility and claudification.

EFFECT: invention ensures high clinical effectiveness.

6 cl, 4 dwg, 8 tbl, 13 ex

FIELD: agriculture.

SUBSTANCE: invention concerns agriculture, and feed production particularly. The method of complete feed stabilisation involves addition of a stabiliser - IFO-6ET (6-ethoxy-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline) in the ratio of 50 to 150 grams per ton. Thus, when cattle feeds on such feed it is less affected by negative influence of lipo- and hydroperoxide products.

EFFECT: inhibition of oxidation of nutrient and biologically active substances of the feed.

3 tbl, 1 ex

FIELD: fodder production.

SUBSTANCE: method for preparing fodder for ruminant animals involves milling and extrusion of grains and carbamide. As grains method involves using rye and sorghum that are wetted with carbamide solution before extrusion wherein 10-11 l of water at temperature 70-80°C and 10-11 kg of carbamide are used per 100 kg of grains. Extrusion is carried out at humidity 19-22%, temperature 130-140°C and under pressure 3.5-4.0 MPa. Method provides decreasing toxicity of carbamide, elimination of anti- nutritive substances from rye and sorghum grains, decreasing hydrolysis of proteins in rumen of ruminant animals.

EFFECT: improved preparing method of fodder.

2 tbl

FIELD: fodder production.

SUBSTANCE: the suggested method deals with reducing green plants and treating them with a filler and fodder additives with pressure and temperature, moreover, the treatment mentioned should be fulfilled in a press-extruder at pressure ranged 20-30 kg/sq.cm and temperature being about 60-80°C. with zeolite at the quantity of 0.5% against fodder's mass and ammonium carbonate at the quantity of 0.5% against fodder's mass. The innovation enables to increase fodder's nutritive value and prolong its storage period.

EFFECT: higher efficiency.

4 ex, 1 tbl

FIELD: agriculture, in particular, preparing of feeds for animals.

SUBSTANCE: method involves steaming-through raw material impregnated with acid solution; grinding raw material and delivering into reactor; sealing reactor; holding raw material under reduced pressure in reactor; feeding hot acid solution into reactor; providing impregnation of raw material with acid solution and hydrolysis under excessive pressure during time period of up to 3 hours; maintaining temperature of 85-100 C in reactor during hydrolysis process; upon termination of hydrolysis process, drawing acid solution from reactor through pipeline into working reservoir, wherein neutralizing acid using reactant having acidity of 6.0-7.0; drawing neutralized liquid from reservoir back into reactor and repeatedly impregnating raw material with liquid; holding raw material within reactor during 5-25 min; drawing liquid from reactor into reservoir and controlling its acidity; in case of occurrence of acidic reaction, providing liquid neutralization until pH value is 6.0-7.0; drawing liquid back into reactor containing raw material and impregnating the latter with liquid; repeating cycle until neutrality is stabilized within the range of pH=6.0-7.0 and drawing working liquid into reservoir; unsealing reactor; withdrawing and using resultant product as animal feed. Apparatus has reactor formed as reservoir with cover to be opened or hermetically closed, and working reservoir with cover to be opened and hermetically closed. Vacuum type delivery pump, hot water and gas generator are connected to reactor and working reservoir through pipelines equipped with locking-and-adjusting valves. Reactor and working reservoir are furnished with controlling and measuring instruments and safety-bypass valve.

EFFECT: improved quality of feeds and reduced power consumption.

6 cl, 1 dwg

FIELD: animal science, swine breeding.

SUBSTANCE: during the period of growing and fattening the youngsters for the purpose of increasing the performance in youngsters in case of simultaneous deficiency of selenium and iodine it is necessary to supplement the diet with microadditives. According the technique mentioned one should apply potassium iodide introduced subcutaneously at the dosage of about 6-9 mg/swine on the 60-90th d of their life, and sodium selenite introduced perorally at the dosage of 0.5 mg/kg feedstuff during the whole period of raising. The innovation enables to increase average daily body weight gains by 20.5%, shorten the age to achieve body weight of 100 kg by 24 d and decrease the expenditure of feedstuff per 1 kg body weight gain by 17.2%.

EFFECT: higher efficiency.

2 tbl

FIELD: veterinary science.

SUBSTANCE: the present innovation deals with preparations and method for treating parasitosis in animals. The suggested curative-fodder additive contains, weight%: univerm 0.5-1.0; albendasol 0.05-0.1; fodder filler as concentrated feedstuffs and water - the rest. Water should be introduced into the additive to achieve 25-30% moisture of the mixture. While carrying out antiparasitic treatments animals should be fed with an antiparasitic preparation in its granulated preparative form in the dosages of 1.5-7.0 g/kg body weight, once for 3 d. Application of the present innovation enables to increase therapeutic efficiency and widen action range of antiparasitic treatments in animals.

EFFECT: higher efficiency.

3 cl, 6 ex, 5 tbl

FIELD: veterinary medicine.

SUBSTANCE: preparation has riboxin, glycolysis activator, vitamin B12, ascorbic acid, citric acid and glucose. The preparation calcium glycerophosphate as the glycolysis activator and additionally has succinic and folic acid and fructose taken in the following ingredient proportions in % by mass: riboxin -10,0-40, calcium glycerophosphate - 30,0-40,0, vitamin B12 - 0.02-0.04, ascorbic acid - 2-4, citric acid - 2-4, succinic acid - 2-4, folic acid - 1-2, fructose 5-10, glucose to 100.

EFFECT: increased laying ability of hens; reduced fodder consumption.

Up!